|
Index of reports
> Cases with Nausea (31)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Zofran (Ondansetron) where reactions include nausea. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 31 Next >>
Possible Zofran side effects in 67 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-22
Patient: 67 year old female
Reactions: Fatigue, Nausea, Herpes Zoster
Drug(s) suspected as cause:
Ebastine
Dosage: 10 mg, unk
Indication: Faecaloma
Ebastine
Indication: Pruritus
Halaven
Dosage: unk
Indication: Faecaloma
Start date: 2012-06-19
Halaven
Dosage: 1.58 mg, unk
Indication: Pruritus
Start date: 2012-06-26
Loratadine
Indication: Pruritus
Loratadine
Indication: Faecaloma
Neulasta
Indication: Pruritus
Neulasta
Dosage: unk
Indication: Faecaloma
Solu-Medrol
Dosage: 20 mg, unk
Indication: Faecaloma
Start date: 2012-06-26
Solu-Medrol
Indication: Pruritus
Zantac
Indication: Pruritus
Zantac
Dosage: 50 mg, unk
Indication: Faecaloma
Start date: 2012-06-26
Zofran
Dosage: 8 mg, unk
Indication: Faecaloma
Start date: 2012-06-26
Zofran
Indication: Pruritus
Other drugs received by patient: Acebutolol; Nexium
Possible Zofran side effects in female
Reported by a consumer/non-health professional from France on 2012-08-21
Patient: female
Reactions: Fatigue, Nausea, Herpes Zoster
Drug(s) suspected as cause:
Ebsatine
Indication: Faecaloma
Ebsatine
Indication: Pruritus
Halaven
Dosage: 1.58 mg/day
Start date: 2012-06-26
Halaven
Dosage: unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-19
Loratadine
Indication: Pruritus
Loratadine
Indication: Faecaloma
Neulasta
Dosage: unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-27
Solu-Medrol
Dosage: 20 mg/day
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-26
Zantac
Dosage: 50 mg/day
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-26
Zofran
Dosage: 8 mg/day
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-26
Other drugs received by patient: Acebutolol; Nexium
Possible Zofran side effects in female
Reported by a physician from France on 2012-08-15
Patient: female
Reactions: Fatigue, Pruritus, Nausea, Faecaloma, Herpes Zoster
Drug(s) suspected as cause:
Ebastine
Indication: Pruritus
Halaven
Dosage: 1.58mg per day
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-26
Loratadine
Indication: Pruritus
Neulasta
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-27
Solu-Medrol
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-26
Zantac
Dosage: 50mg per day
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-26
Zofran
Dosage: 8mg per day
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-26
Other drugs received by patient: Cyclophosphamide; Fluorouracil; Methotrexate; Nexium; Bevacizumab; Doxorubicin HCL; Acebutolol
Possible Zofran side effects in 54 year old female
Reported by a physician from United States on 2012-08-13
Patient: 54 year old female, weighing 55.8 kg (122.7 pounds)
Reactions: Vomiting, Nausea, Diarrhoea, Dehydration, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aleve
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-13
Doxycycline HCL
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-20
Motrin
Administration route: Oral
Indication: Pain
Start date: 2011-12-19
End date: 2012-06-11
MS Contin
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-12
Unknown Medication
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-18
Zofran
Indication: Nausea
Start date: 2012-06-17
End date: 2012-06-19
Other drugs received by patient: Vitamin B-12; Ascorbic Acid; Pamidronate Disodium; Vitamine E; Multiple Vitamin; Folic Acid; Vitamin D
Possible Zofran side effects in 54 year old female
Reported by a physician from United States on 2012-07-17
Patient: 54 year old female, weighing 55.8 kg (122.7 pounds)
Reactions: Vomiting, Diarrhoea, Nausea, Dehydration, Blood Creatine Increased, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aleve
Dosage: 220 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-13
Doxycycline
Dosage: 100 mg, bid
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-20
Motrin
Dosage: 800 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2011-12-19
End date: 2012-06-12
MS Contin
Dosage: 15 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-12
Study Drug
Dosage: 45 mg, unk
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-18
Zofran
Dosage: 4 mg, q6h
Indication: Nausea
Start date: 2012-06-17
End date: 2012-06-19
Other drugs received by patient: Theragran-M / 00610701 /; Vitamin D; Folic Acid; B12 / 00056201 /; Vitamin C / 00008001 /; Pamidronate Disodium; Vitamin E / 00110501 /
Possible Zofran side effects in 54 year old female
Reported by a physician from United States on 2012-07-13
Patient: 54 year old female, weighing 55.8 kg (122.7 pounds)
Reactions: Vomiting, Diarrhoea, Nausea, Dehydration, Blood Creatine Increased, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aleve
Dosage: 220 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-13
Doxycycline
Dosage: 100 mg, bid
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-20
Motrin
Dosage: 800 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2011-12-19
End date: 2012-06-12
MS Contin
Dosage: 15 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-12
Study Drug
Dosage: 45 mg, unk
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-18
Zofran
Dosage: 4 mg, q6h
Indication: Nausea
Start date: 2012-06-17
End date: 2012-06-19
Other drugs received by patient: Vitamin D; Theragran-M / 00610701 /; B12 / 00056201 /; Vitamin C / 00008001 /; Vitamin E / 00110501 /; Pamidronate Disodium; Folic Acid
Possible Zofran side effects in male
Reported by a physician from Belgium on 2012-07-09
Patient: male, weighing 73.0 kg (160.6 pounds)
Reactions: Colitis Ischaemic, Vomiting, Nausea, Rectal Haemorrhage, Constipation, Faecaloma, Diarrhoea, Abdominal Symptom, Diarrhoea Haemorrhagic, Feeling of Body Temperature Change, Muscle Spasms, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Indication: Testicular Neoplasm
Start date: 2012-04-17
End date: 2012-05-08
Zofran
Start date: 2012-04-17
End date: 2012-05-08
Zofran
Dosage: 8mg twice per day
Administration route: Oral
Indication: Nausea
Start date: 2012-04-18
End date: 2012-05-11
Other drugs received by patient: Solu-Medrol; Medrol
Possible Zofran side effects in 54 year old female
Reported by a physician from United States on 2012-07-06
Patient: 54 year old female, weighing 55.8 kg (122.7 pounds)
Reactions: Vomiting, Nausea, Diarrhoea, Dehydration, Blood Creatine Increased, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aleve
Dosage: 220 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-13
Doxycycline Hyclate
Dosage: 100 mg, bid
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-20
Motrin
Dosage: 800 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2011-12-19
End date: 2012-06-12
MS Contin
Dosage: 15 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-12
Study Drug
Dosage: 45 mg, unk
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-18
Zofran
Dosage: 4 mg, q6h
Indication: Nausea
Start date: 2012-06-17
End date: 2012-06-19
Other drugs received by patient: Pamidronate Disodium; Folic Acid; Theragran-M / 00610701 /; B12 / 00056201 /; Vitamin E / 00110501 /; Vitamin C / 00008001 /; Vitamin D
Possible Zofran side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-19
Patient: 65 year old female
Reactions: Weight Decreased, Blood Bilirubin Increased, Pruritus, Wrong Technique in Drug Usage Process, Treatment Noncompliance, Transaminases Increased, Blood Urine Present, Dysphagia, Stomatitis, Tablet Physical Issue, Anaemia, Poor Quality Drug Administered, Vulvovaginal Pain, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Haemorrhoidal Haemorrhage, Photophobia, Sinusitis, Nausea, Haemorrhoids, Underdose, Eye Pain, Blood Glucose Decreased, Dysgeusia, Product Packaging Issue, Disease Recurrence, Hypophagia, Alopecia, Dysuria, Feeling Abnormal, Asthenia, DRY Eye, Leukopenia
Drug(s) suspected as cause:
Acetaminophen
Indication: Product Used FOR Unknown Indication
Aspirin
Dosage: 81 mg; qd; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Cozaar
Dosage: 50 mg; qd; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Nuvigil
Dosage: 50 mg; qd; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Peginterferon Alfa-2A
Dosage: qw; sc
Indication: Product Used FOR Unknown Indication
Pradaxa
Dosage: 150 mg; bid; po, 75 mg; qd; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ribavirin
Dosage: 600 mg; bid; po
Administration route: Oral
Rythmol
Dosage: 325 mg; bid; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Toprol-XL
Dosage: 50 mg; qd; po, 25 mg; qd; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 800 mg; tid; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Zofran
Dosage: 8 mcg; prn; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Hydrochloride; Reglan; Metoclopramide
Possible Zofran side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-19
Patient: 65 year old female
Reactions: Blood Bilirubin Increased, Weight Decreased, Pruritus, Wrong Technique in Drug Usage Process, Treatment Noncompliance, Transaminases Increased, Dysphagia, Blood Urine Present, Stomatitis, Tablet Physical Issue, Anaemia, Poor Quality Drug Administered, Vulvovaginal Pain, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Haemorrhoidal Haemorrhage, Photophobia, Sinusitis, Nausea, Haemorrhoids, Underdose, Eye Pain, Blood Glucose Decreased, Dysgeusia, Product Packaging Issue, Disease Recurrence, Alopecia, Dysuria, Hypophagia, Feeling Abnormal, DRY Eye, Asthenia, Leukopenia
Drug(s) suspected as cause:
Aspirin
Dosage: 81 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Cozaar
Dosage: 50 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Nuvigil
Dosage: 50 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Peginterferon Alfa-2A
Dosage: qw;sc
Indication: Product Used FOR Unknown Indication
Pradaxa
Dosage: 150 mg;bid;po 75 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ribavirin
Dosage: 600 mg;bid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Rythmol
Dosage: 325 mg;bid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Toprol-XL
Dosage: 50 mg;qd;po 25 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 800 mg;tid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Zofran
Dosage: 8 mg;prn;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Metoclopramide Hydrochloride; Reglan
Possible Zofran side effects in 76 year old female
Reported by a physician from Austria on 2012-05-24
Patient: 76 year old female, weighing 85.0 kg (187.0 pounds)
Reactions: Blood Pressure Systolic Decreased, Nausea
Drug(s) suspected as cause:
Zofran
Possible Zofran side effects in 83 year old female
Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-05-08
Patient: 83 year old female
Reactions: Vomiting, Nausea, Bacteraemia, Staphylococcal Infection, International Normalised Ratio Increased, Gastroenteritis Viral, Spondylitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Citalopram Hydrobromide
Dosage: 10 mg, daily dose, long term
Administration route: Oral
Sintrom
Dosage: 3 mg, daily
Administration route: Oral
Indication: Atrial Fibrillation
End date: 2012-02-20
Torsemide
Dosage: 10 mg, daily dose, long term
Administration route: Oral
Zofran
Indication: Vomiting
Zofran
Dosage: 4 mg, per 8 hours
Indication: Nausea
Start date: 2012-02-15
End date: 2012-03-04
Other drugs received by patient: Floxapen; Digoxin; Calcimagon-D3; Morphin HCL; Zolpidem; Laxoberon; Digoxin
Possible Zofran side effects in 58 year old female
Reported by a physician from United States on 2012-04-27
Patient: 58 year old female
Reactions: Nasopharyngitis, Malaise, Vomiting, Nausea, Drug Ineffective, Ill-Defined Disorder, Cough
Drug(s) suspected as cause:
Advair Diskus 100 / 50
Avandamet
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Chemotherapy
Zofran
Dosage: 8mg unknown
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Zofran side effects in 78 year old female
Reported by a consumer/non-health professional from United States on 2012-04-27
Patient: 78 year old female
Reactions: Vomiting, Nausea, Drug Ineffective, Abdominal Distension, Rash, Gastric Disorder
Drug(s) suspected as cause:
Cinryze
Dosage: 1000unit three times per week
Indication: Angioedema
Start date: 2006-01-01
Zofran
Indication: Vomiting
Possible Zofran side effects in
Reported by a consumer/non-health professional from United States on 2012-04-27
Patient: , weighing 79.5 kg (174.9 pounds)
Reactions: Weight Decreased, Pruritus, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Photophobia, Product Quality Issue, Blood Urine Present, Dysphagia, Stomatitis, Nausea, Underdose, Poor Quality Drug Administered, Eye Pain, Dysgeusia, Blood Glucose Decreased, Bladder Spasm, Vaginal Inflammation, Alopecia, DRY Eye, Asthenia
Drug(s) suspected as cause:
Rythmol SR
Indication: Product Used FOR Unknown Indication
Zofran
Indication: Product Used FOR Unknown Indication
Possible Zofran side effects in 48 year old female
Reported by a consumer/non-health professional from United States on 2012-04-27
Patient: 48 year old female
Reactions: Vomiting, Nausea, Diarrhoea, Urinary Tract Infection, Constipation, Skin Reaction
Drug(s) suspected as cause:
Ondansetron
Dosage: 8mg as required
Administration route: Oral
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2009-11-30
Tykerb
Dosage: 1250mg per day
Administration route: Oral
Indication: Breast Cancer
Start date: 2008-01-01
Zofran
Administration route: Oral
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2000-01-01
End date: 2000-08-01
Other drugs received by patient: Xeloda; Steroid; Omeprazole; Coumadin; Chemotherapy
Possible Zofran side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-03
Patient: 65 year old female
Reactions: Blood Bilirubin Increased, Weight Decreased, Wrong Technique in Drug Usage Process, Pruritus, Treatment Noncompliance, Transaminases Increased, Blood Urine Present, Stomatitis, Dysphagia, Tablet Physical Issue, Anaemia, Poor Quality Drug Administered, Vulvovaginal Pain, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Haemorrhoidal Haemorrhage, Photophobia, Sinusitis, Nausea, Haemorrhoids, Underdose, Eye Pain, Blood Glucose Decreased, Dysgeusia, Product Packaging Issue, Disease Recurrence, Alopecia, Hypophagia, Dysuria, DRY Eye, Feeling Abnormal, Asthenia, Leukopenia
Drug(s) suspected as cause:
Aspirin
Dosage: 81 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Cozaar
Dosage: 50 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Nuvigil
Dosage: 50 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Peginterferon Alfa-2A
Dosage: ;qw;sc
Indication: Product Used FOR Unknown Indication
Pradaxa
Dosage: 150 mg;bid;po 75 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ribavirin
Dosage: 600 mg;bid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Rythmol
Dosage: 325 mg;bid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Toprol-XL
Dosage: 50 mg;qd;po 25 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Tylenol (Caplet)
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 800 mg;tid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Zofran
Dosage: 8 mg;prn;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Metoclopramide; Hydrochloride; Reglan
Possible Zofran side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-03
Patient: 65 year old female
Reactions: Blood Bilirubin Increased, Weight Decreased, Pruritus, Wrong Technique in Drug Usage Process, Treatment Noncompliance, Transaminases Increased, Blood Urine Present, Dysphagia, Stomatitis, Tablet Physical Issue, Anaemia, Poor Quality Drug Administered, Vulvovaginal Pain, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Haemorrhoidal Haemorrhage, Photophobia, Sinusitis, Nausea, Haemorrhoids, Underdose, Eye Pain, Blood Glucose Decreased, Dysgeusia, Product Packaging Issue, Disease Recurrence, Alopecia, Dysuria, Hypophagia, Asthenia, DRY Eye, Feeling Abnormal, Leukopenia
Drug(s) suspected as cause:
Aspirin
Dosage: 81 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Cozaar
Dosage: 50 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Nuvigil
Dosage: 50 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Peginterferon Alfa-2A
Dosage: ;qw;sc
Pradaxa
Dosage: 150 mg;bid;po 75 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ribavirin
Dosage: 600 mg;bid;po
Administration route: Oral
Rythmol
Dosage: 325 mg;bid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Toprol-XL
Dosage: 50 mg;qd;po 25 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Tylenol (Caplet)
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 800 mg;tid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Zofran
Dosage: 8 mg;prn;po
Administration route: Oral
Other drugs received by patient: Hydrochloride; Metoclopramide; Reglan
Possible Zofran side effects in male
Reported by a physician from France on 2012-04-02
Patient: male, weighing 63.0 kg (138.6 pounds)
Reactions: Abdominal Pain, Nausea, Intestinal Obstruction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Acetaminophen and Tramadol HCL
Dosage: 1unit twice per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-06
End date: 2012-02-15
Morphine Sulfate
Dosage: 30mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-06
End date: 2012-02-15
Zofran
Dosage: 8mg twice per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-06
End date: 2012-02-15
Other drugs received by patient: Debridat; Spasfon; Doxorubicin HCL; Isentress; Vinblastine Sulfate; Norvir; Creon; Motilium; Bactrim DS; Polaramine; Duspatalin; Prezista; Valacyclovir Hydrochloride; Dacarbazine; Bleomycin Sulfate; Emend; Intelence
Possible Zofran side effects in female
Reported by a consumer/non-health professional from Australia on 2012-03-22
Patient: female, weighing 53.0 kg (116.6 pounds)
Reactions: Nausea, Maternal Exposure During Pregnancy, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zofran
Possible Zofran side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-22
Patient: 66 year old female, weighing 59.4 kg (130.7 pounds)
Reactions: Confusional State, Abdominal Pain, Vomiting, Blood Urea Increased, Nausea, Mental Status Changes, Cognitive Disorder, Headache, Pallor, Malaise, Fatigue, Posterior Reversible Encephalopathy Syndrome, Disturbance in Attention, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Colace (Docusate Sodium)
Dosage: 100 mg, bid
Indication: Constipation
Start date: 2009-04-02
End date: 2009-08-28
Ferrous Gluconate (Ferrous Gluconate) Tablet
Dosage: 325 mg, bid, oral
Administration route: Oral
Indication: Iron Deficiency
Start date: 2009-02-27
End date: 2009-08-28
Lortab
Dosage: 1 df every 6 hours as needed
Indication: Analgesic Therapy
Start date: 2009-08-25
End date: 2009-08-28
Lortab
Dosage: 1 df every 6 hours as needed
Indication: Analgesic Therapy
Start date: 2009-04-02
End date: 2009-06-29
Megace
Dosage: 3 df, qd, oral
Administration route: Oral
Indication: Appetite Disorder
Pioglitazone
Dosage: 30 mg, qd, oral
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-06-04
Ranitidine
Dosage: 150 mg, bid
Indication: Ulcer
End date: 2009-08-28
Simvastatin
Dosage: 40 mg, bid
Indication: Blood Cholesterol
Start date: 2009-02-27
End date: 2009-08-28
Sunitinib Malate
Dosage: 50 mg, bid
Indication: Renal Cancer
Start date: 2009-06-01
End date: 2009-08-28
Uncodeable ^investigational Drug^ (Uncodeable ^investigational Drug^)
Indication: Prophylaxis
Start date: 2009-05-12
End date: 2009-07-07
Uncodeable ^unclassifiable^ (Uncodeable ^unclassifiable^)
Dosage: qd 5 days a week x 3 weeks
Indication: Product Used FOR Unknown Indication
Start date: 2009-03-16
End date: 2009-04-06
Zofran
Dosage: 1 df every 6 hours as needed, oral
Administration route: Oral
Indication: Nausea
End date: 2009-08-28
Other drugs received by patient: Artificial Tears; Aspirin; Actonel
Possible Zofran side effects in female
Reported by a consumer/non-health professional from Australia on 2012-03-05
Patient: female
Reactions: Nausea, Dehydration, Maternal Exposure During Pregnancy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zofran
Possible Zofran side effects in female
Reported by a consumer/non-health professional from United States on 2012-02-14
Patient: female, weighing 74.8 kg (164.6 pounds)
Reactions: Nausea, Vomiting Projectile, Drug Ineffective, Headache, Aggression, Anger, Disturbance in Attention, Nervous System Disorder, Drug Administration Error, Memory Impairment
Drug(s) suspected as cause:
Fioricet
Dosage: unk
Administration route: Oral
Indication: Headache
Lortab
Dosage: unk
Indication: Headache
Pristiq
Indication: Insomnia
Pristiq
Dosage: 100 mg, daily
Indication: Stress AT Work
Start date: 2011-06-01
Promethazine
Indication: Nausea
Promethazine
Dosage: unk
Indication: Vomiting Projectile
Xanax
Dosage: unk
Indication: Insomnia
Zofran
Indication: Nausea
Zofran
Dosage: unk
Indication: Vomiting Projectile
Possible Zofran side effects in 34 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-14
Patient: 34 year old female, weighing 74.8 kg (164.6 pounds)
Reactions: Drug Ineffective, Nausea, Vomiting Projectile, Headache, Hypoaesthesia, Aggression, Disturbance in Attention, Anger, Memory Impairment
Drug(s) suspected as cause:
Butalbital Acetaminophen Caffeine
Indication: Headache
Lortab
Indication: Headache
Phenergan
Indication: Vomiting Projectile
Start date: 2011-01-01
Phenergan
Indication: Nausea
Start date: 2011-01-01
Pristiq
Dosage: extended release tablet 100 mg to 50 mg weaning dose
Administration route: Oral
Start date: 2011-01-01
End date: 2011-01-01
Pristiq
Dosage: extended release tablet 50 mg splitted
Administration route: Oral
Start date: 2011-01-01
Pristiq
Dosage: extended release tablet
Administration route: Oral
Indication: Insomnia
Start date: 2011-06-01
Pristiq
Dosage: extended release tablet 100 mg to 50 mg weaning dose
Administration route: Oral
Start date: 2011-01-01
End date: 2011-01-01
Pristiq
Dosage: extended release tablet
Administration route: Oral
Indication: Stress AT Work
Start date: 2011-06-01
Pristiq
Dosage: extended release tablet 50 mg splitted
Administration route: Oral
Start date: 2011-01-01
Xanax
Administration route: Oral
Indication: Sleep Disorder
Zofran
Indication: Nausea
Start date: 2011-01-01
Zofran
Indication: Vomiting Projectile
Start date: 2011-01-01
Possible Zofran side effects in 74 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-01
Patient: 74 year old female
Reactions: Anxiety, Torsade DE Pointes, Nausea, Hypomagnesaemia, Pain, Atrioventricular Block First Degree, Hypokalaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Amiodarone HCL
Indication: Ventricular Tachycardia
Carvedilol
Indication: Product Used FOR Unknown Indication
Citalopram Hydrobromide
Indication: Product Used FOR Unknown Indication
Zofran
Dosage: 4 mg, intravenous
Indication: Nausea
Other drugs received by patient: Fentanyl
Possible Zofran side effects in 74 year old female
Reported by a consumer/non-health professional from United States on 2012-01-18
Patient: 74 year old female
Reactions: Nausea, Pain, Treatment Noncompliance, Long QT Syndrome, Sinus Bradycardia, Hypokalaemia, Torsade DE Pointes, Anxiety, Hypomagnesaemia, Atrioventricular Block First Degree
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Amiodarone HCL
Indication: Ventricular Tachycardia
Carvedilol
Indication: Product Used FOR Unknown Indication
Citalopram Hydrobromide
Indication: Product Used FOR Unknown Indication
Zofran
Dosage: (4 mg), intravenous
Indication: Nausea
Other drugs received by patient: Fentanyl
Possible Zofran side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-12
Patient: female, weighing 74.8 kg (164.6 pounds)
Reactions: Nausea, Vomiting Projectile, Drug Ineffective, Hypoaesthesia, Headache, Aggression, Disturbance in Attention, Anger, Memory Impairment
Drug(s) suspected as cause:
Fioricet
Dosage: unk
Indication: Headache
Lortab
Dosage: unk
Indication: Headache
Pristiq
Dosage: unk
Administration route: Oral
Indication: Insomnia
Start date: 2011-01-01
Pristiq
Dosage: 100 mg,daily
Administration route: Oral
Indication: Stress AT Work
Start date: 2011-06-01
End date: 2011-01-01
Promethazine
Indication: Vomiting Projectile
Promethazine
Dosage: unk
Indication: Nausea
Xanax
Dosage: unk
Administration route: Oral
Indication: Sleep Disorder
Zofran
Indication: Nausea
Zofran
Dosage: unk
Indication: Vomiting Projectile
Possible Zofran side effects in 64 year old female
Reported by a consumer/non-health professional from United States on 2012-01-09
Patient: 64 year old female, weighing 59.0 kg (129.8 pounds)
Reactions: Abdominal Pain, Thrombosis, Contusion, Headache, Constipation, Erythema, Hunger, Hot Flush, Oedema Peripheral, DRY Mouth, Nail Disorder, Dizziness, Decreased Appetite, Epistaxis, Vomiting, Pain in Extremity, Nausea, Hypoaesthesia, DRY Skin, Gastric Haemorrhage, Dysgeusia, Lung Disorder, Syncope, Neoplasm Malignant, Ageusia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: no of treatments:6,restarted in aug-2011, 02sep11
Indication: Breast Cancer in Situ
Start date: 2007-11-20
Lovenox
Paclitaxel
Indication: Breast Cancer in Situ
Paclitaxel
Dosage: no of treatments:6,restarted in aug-2011, 02sep11
Indication: Breast Cancer in Situ
Platinol
Dosage: no of treatments:6,restarted in aug-2011,
Indication: Breast Cancer in Situ
Start date: 2007-11-20
Zofran
Indication: Premedication
Other drugs received by patient: Iron; Vitamin D; Multi-Vitamins
Possible Zofran side effects in 65 year old female
Reported by a individual with unspecified qualification from United States on 2011-12-16
Patient: 65 year old female
Reactions: Weight Decreased, Blood Bilirubin Increased, Wrong Technique in Drug Usage Process, Pruritus, Treatment Noncompliance, Transaminases Increased, Blood Urine Present, Dysphagia, Stomatitis, Tablet Physical Issue, Anaemia, Poor Quality Drug Administered, Vulvovaginal Pain, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Haemorrhoidal Haemorrhage, Photophobia, Sinusitis, Nausea, Haemorrhoids, Underdose, Eye Pain, Blood Glucose Decreased, Dysgeusia, Product Packaging Issue, Disease Recurrence, Dysuria, Alopecia, Hypophagia, Asthenia, Feeling Abnormal, DRY Eye, Leukopenia
Drug(s) suspected as cause:
Acetaminophen
Indication: Product Used FOR Unknown Indication
Aspirin
Dosage: 81 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Cozaar
Dosage: 50 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Nuvigil
Dosage: 50 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Peginterferon Alfa-2A
Dosage: ;qw;sc
Pradaxa
Dosage: 150 mg;bid;po, 75 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ribavirin
Dosage: 600 mg;bid;po
Administration route: Oral
Rythmol
Dosage: 325 mg;bid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Toprol-XL
Dosage: 50 mg;qd;po, 25 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 800 mg;tid;po
Indication: Product Used FOR Unknown Indication
Zofran
Dosage: 8 mg; pan; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Metoclopramide HCL; Reglan
Possible Zofran side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-21
Patient: female, weighing 59.4 kg (130.7 pounds)
Reactions: Confusional State, Abdominal Pain, Vomiting, Nausea, Mental Status Changes, Cognitive Disorder, Headache, Fatigue, Malaise
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Amlodipine
Dosage: 10 mg (10 mg, 1 in 1 d) oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Carvedilol
Dosage: 50 mg (25 mg, 2 in 1 d), unknown
Indication: Product Used FOR Unknown Indication
Colace (Docusate Sodium)
Dosage: 200 mg (100 mg, 2 in 1 d)
Indication: Product Used FOR Unknown Indication
Fergon (Ferrous Gluconage)
Dosage: 650 mg (325 mg, 2 in 1 d), oral
Administration route: Oral
Indication: Iron Deficiency
Lortab
Dosage: 1 dosage forms 6 hr)
Indication: Product Used FOR Unknown Indication
Magnesium Citrate (Magnesium Citrate)
Dosage: oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Megace
Dosage: oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Pioglitazone Hydrochloride
Dosage: 30 mg (30 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ranitidine Hydrochloride
Dosage: 300 mg (150 mg, 2 in 1 d)
Indication: Product Used FOR Unknown Indication
Simvastatin
Dosage: 80 mg (40 mg, 2 in 1 d) oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Sunitinib Malate
Dosage: 100 mg (50 mg, 2 in 1 d) oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Tessalon
Dosage: 300 mg (100 mg, 3 in 1 d), oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Zofran
Dosage: 1 dosage forms, 6 hr, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Extra Strength Tylenol; Aspirin; Cipro; Actonel; Artificial Tears (Hypromellose)
Page 1 Next >>
|
